References
-
1) Engeletin Alleviates the Inflammation and Apoptosis in Intervertebral Disc Degeneration via Inhibiting the NF-κB and MAPK Pathways.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: J INFLAMM RESImpactFactor: 4.5DOI: doi\:10.2147/JIR.S371809PMID: 36238766 -
2) Ozanimod-dependent activation of SIRT3/NF-κb/AIM2 pathway attenuates secondary injury after intracerebral hemorrhage.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: MOL NEUROBIOLImpactFactor: 4.6DOI: 10.1007/s12035-022-03137-2PMID: 36417102 -
3) Bisdemethoxycurcumin Alleviates Dextran Sodium Sulfate-Induced Colitis via Inhibiting NLRP3 Inflammasome Activation and Modulating the Gut Microbiota in Mice.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: ANTIOXIDANTS-BASELImpactFactor: 7DOI: 10.3390/antiox11101994PMID: 36290717 -
4) Quercetin Protects Ethanol-Induced Hepatocyte Pyroptosis via Scavenging Mitochondrial ROS and Promoting PGC-1α-Regulated Mitochondrial Homeostasis in L02 Cells.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: OXID MED CELL LONGEVDOI: 10.1155/2022/4591134PMID: 35879991 -
5) Advanced oxidation protein products induce annulus fibrosus cell senescence through a NOX4-dependent, MAPK-mediated pathway and accelerate intervertebral disc degeneration.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: PEERJImpactFactor: 2.3DOI: 10.7717/peerj.13826PMID: 35935259 -
6) Epigallocatechin‐3‐gallate reduces neutrophil extracellular trap formation and tissue injury in severe acute pancreatitis.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: J LEUKOCYTE BIOLImpactFactor: 3.6DOI: 10.1002/JLB.3A0322-151RPMID: 35983712 -
7) Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathway.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: MOL MEDImpactFactor: 6DOI: 10.1186/s10020-022-00508-2PMID: 35842576 -
8) Alamandine, a new member of the renin-angiotensin system (RAS), attenuates collagen-induced arthritis in mice via inhibiting cytokine secretion in synovial fibroblasts.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: PEPTIDESImpactFactor: 2.8DOI: 10.1016/j.peptides.2022.170816PMID: 35609788 -
9) NLRP3/Caspase-1-Mediated Pyroptosis of Astrocytes Induced by Antipsychotics Is Inhibited by a Histamine H1 Receptor-Selective Agonist.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: FRONT AGING NEUROSCIImpactFactor: 4.1DOI: 10.3389/fnagi.2022.847561PMID: 35615587 -
10) Bacterial Toxin‐Responsive Biomimetic Nanobubbles for Precision Photodynamic Therapy against Bacterial Infections.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: ADV HEALTHC MATERImpactFactor: 10DOI: 10.1002/adhm.202200698PMID: 35836329 -
11) Exosome modification to better alleviates endoplasmic reticulum stress induced chondrocyte apoptosis and osteoarthritis.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: BIOCHEM PHARMACOLImpactFactor: 5.3DOI: 10.1016/j.bcp.2022.115343PMID: 36370754 -
12) Exercise-induced neuroprotection against cerebral ischemia/reperfusion injury is mediated via alleviating inflammasome-induced pyroptosis.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: EXP NEUROLImpactFactor: 4.6DOI: 10.1016/j.expneurol.2021.113952PMID: 34921847 -
13) CysLT2R Antagonist HAMI 3379 Ameliorates Post-Stroke Depression through NLRP3 Inflammasome/Pyroptosis Pathway in Gerbils.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: BRAIN SCIImpactFactor: 3.3DOI: 10.3390/brainsci12080976PMID: 35892417 -
14) Knockdown of PHLDA1 Alleviates Necrotizing Enterocolitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: IMMUNOL INVESTImpactFactor: 2.9DOI: 10.1080/08820139.2022.2161910PMID: 36576246 -
15) New insights of necroptosis and immune infiltration in sepsis-induced myocardial dysfunction from bioinformatics analysis through RNA-seq in mice.
Product: IL1 beta Antibody (#AF5103)Year: 2022Journal: Front Cell Infect MicrobiolImpactFactor: 4.6DOI: 10.3389/fcimb.2022.1068324PMID: 36619743